Fuchs, Claudia D.
Trauner, Michael http://orcid.org/0000-0002-1275-6425
Article History
Accepted: 3 December 2021
First Online: 14 February 2022
Competing interests
: M.T. discloses that he has served as speaker for Falk Foundation, Gilead, Intercept and MSD; he has advised for Albireo, BiomX, Boehringer Ingelheim, Falk Pharma GmbH, Genfit, Gilead, Intercept, Janssen, MSD, Novartis, Phenex, Regulus and Shire. He further received travel grants from Abbvie, Falk Pharma GmbH, Gilead, and Intercept and research grants from Albireo, Alnylam, Cymabay, Falk, Gilead, Intercept, MSD Takeda and UltraGenyx. He is also co-inventor of patents on the medical use of NorUDCA filed by the Medical Universities of Graz and Vienna. C.D.F. received travel grants from Gilead, Falk Pharma GmbH and Abbvie.